Il Yang to develope new production process of Tamiflu in Korea.

Published: 2005-11-25 06:58:00

Updated: 2005-11-25 06:58:00

Il Yang has succeeded in the synthesis of Tamiflu bulk material called Oseltamivir for the prevention and treatment of AI (Avian influenza), and filed its registration to the KFDA.

The production process, which was originally taking 16 steps, has been remarkably reduced and its production yie...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK